Clinical Trial Update: Endothelin-Receptor Blockade in Coronary Heart Disease [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating endothelin-receptor blockade in patients with coronary heart disease, focusing on effects on co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Endothelin receptor antagonist (class) (Endothelin receptor antagonist)

Snippet

Sponsor: Medical University of Vienna | Conditions: Coronary Vessels, Endothelins | Phase 1 | Status: COMPLETED